Raj Makkar

Interventional cardiologist / Cardiologist
Cedars-Sinai Heart Institute - Los Angeles, United States

Latest contributions

Bioprosthetic valve failure and structural deterioration – New definitions and treatment options

26 Sep 2017 – From PCR London Valves 2017

TAVI: prediction and prevention of complications

25 Sep 2017 – From PCR London Valves 2017

Randomised trials of TAVI in intermediate-risk patients - Implications for everyday practice

25 Sep 2017 – From PCR London Valves 2017

Potential pitfalls of TAVI in low-risk patients

19 May 2017 – From EuroPCR 2017

The case for cerebral protection during structural heart interventions

18 May 2017 – From EuroPCR 2017

Valvular interventions LIVE demonstration: TAVI

17 May 2017 – From EuroPCR 2017

Consult this session on TAVI presented by P. MacCarthy, an 86-year old patient that includes a LIVE demonstration from the Swiss Cardiovascular Centre, Bern University Hospital - Switzerland.

TAVI registries and durability

16 May 2017 – From EuroPCR 2017

Bioprosthetic valve leaflet thickening and long-term durability

16 May 2017 – From EuroPCR 2017

Consult this session on bioprosthetic valve leaflet thickening and long-term durability from EuroPCR 2017 if you want to find more about mechanisms of bioprosthetic valve failure and definitions of valve durability and clinical data concerning the long-term outcomes after TAVI.

Three most educational cases

09 Apr 2017 – From PCR Tokyo Valves 2017

LIVE demonstration from Massy, France - Optimising TAVI procedure

08 Apr 2017 – From PCR Tokyo Valves 2017

New valves

08 Apr 2017 – From PCR Tokyo Valves 2017

Late breaking trials: Asian registry

09 Apr 2017 – From PCR Tokyo Valves 2017

Imaging of the aortic valve complex for TAVI

07 Apr 2017 – From PCR Tokyo Valves 2017

Trials and registries 2016: what do they mean?

20 Sep 2016 – From PCR London Valves 2016

Consult this session video on the trials and registries 2016 from PCR London Valves 2016.

Martine Gilard

Chairperson

Martine Gilard
Prof. Olaf Wendler

Chairperson

Olaf Wendler

LIVE demonstration: Percutaneous edge-to-edge repair for mixed functional and degenerative mitral regurgitation using a next generation device

20 Sep 2016 – From PCR London Valves 2016

Martine Gilard

Chairperson

Martine Gilard
Prof. Olaf Wendler

Chairperson

Olaf Wendler

Portico - when expertise meets simplicity: key learnings

19 Sep 2016 – From PCR London Valves 2016

Chairperson

Gregory Fontana
Helge Moellmann

Chairperson

Helge Moellmann

Long-term outcomes after TAVI

19 Sep 2016 – From PCR London Valves 2016

Prof. Ran Kornowski

Chairperson

Ran Kornowski
Helge Moellmann

Chairperson

Helge Moellmann

Will PARTNER II change my practice?

20 May 2016 – From EuroPCR 2016

Lars Sondergaard

Chairperson

Lars Sondergaard
Hélène Eltchaninoff

Chairperson

Hélène Eltchaninoff

TAVI: current and future perspectives for adjunctive antithrombotic therapy

19 May 2016 – From EuroPCR 2016

This video is offered by Bayer Pharma AG

Chairperson

George Dangas

Stroke post-TAVI: predictors and preventives

19 May 2016 – From EuroPCR 2016

Chairperson

Raj Makkar

The Portico valve: where expertise meets simplicity. Please join us for case studies to learn more about the true ease of use advantages in prep, placement and control of this system

19 May 2016 – From EuroPCR 2016

Chairperson

Raj Makkar

PCR's Got Talent - round 1: TAVI - part 2

18 May 2016 – From EuroPCR 2016

Philip MacCarthy

Chairperson

Philip MacCarthy
Carlos E. Ruiz

Chairperson

Carlos E. Ruiz

The impact of mitral valve disease in the TAVI patient

22 Sep 2015 – From PCR London Valves 2015

Watch this session if you want to understand the importance of mitral valve disease in the setting of severe aortic stenosis, gain insights as to whether mitral regurgitation will improve after TAVI and learn more about the indications for combined percutaneous valve interventions.

Prof. Jeroen J. Bax

Chairperson

Jeroen Bax
Dr Bernard Prendergast

Chairperson

Bernard Prendergast

TAVI: management of coronary complications

22 May 2015 – From EuroPCR 2015

Genco Yucel

Chairperson

Genco Yucel

TAVI advancements: key learnings and perspectives of the Portico valve programme

20 May 2015 – From EuroPCR 2015

Stephen Worthley

Chairperson

Stephen Worthley

Impact of comorbidities on TAVI outcomes

19 May 2015 – From EuroPCR 2015

Chairperson

Raj Makkar

Can an in-situ recapturable and repositionable TAVI platform influence procedural and patient outcome

21 May 2014 – From EuroPCR 2014

Ganesh Manoharan

Chairperson

Ganesh Manoharan